Remeglurant
Remeglurant (MRZ-8456) acts as a selective, orally active and allosteric antagonist of the mGlu5 receptor, with an IC50 of 13 nM. Remeglurant (MRZ-8456) can be used in the research for dyskinesia in Parkinson’s disease (PD) [1][2].
Product Specifications
CAS Number
1309783-00-3
Product Name Alternative
MRZ-8456
UNSPSC
12352005
Target
MGluR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/remeglurant.html
Smiles
O=C(N1[C@@H](C2=C(CC1)C=CC=C2)C)C3=NN4C=C(C=NC4=C3)Br
Molecular Formula
C17H15BrN4O
Molecular Weight
371.23
References & Citations
[1]Pamela R Westmark, et al. Rescue of Fmr1KO phenotypes with mGluR5 inhibitors: MRZ-8456 versus AFQ-056. Neurobiol Dis. 2018 Nov:119:190-198.|[2]Philippe Huot, et al. Targeting metabotropic glutamate receptors for the treatment of Parkinson's disease. Neurodegener Dis Manag. 2023 Aug;13 (4) :203-206.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MGluR5
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![FITC Anti-Mouse TCRβ Antibody[H57-597]](https://cdn.genprice.uk/products/763/68dd14af061270361e7d3968/imageurl/e-ab-f1123c.webp)